Advanced Memory Research Institute

What Advanced Memory Research Institute does

Advanced Memory Research Institute (AMRI) is a clinical research site based in Toms River, New Jersey, specializing exclusively in clinical trials for memory loss, Alzheimer's disease, and dementia. Founded in 2013, the institute operates from a 6,000 sq ft dedicated research facility at 9 Mule Road, Suite E9, and functions as a core affiliated site within the CenExel national clinical research network. All procedures are overseen by board-certified physicians and trained medical staff, with the organization claiming 50+ years of collective clinical trial experience across its team.

The company's core offerings include execution of pharmaceutical-sponsored clinical trials, no-cost memory evaluations lasting 1-2 hours, Amyloid PET imaging for detection of amyloid plaques, and infusion services within dedicated suites for intravenous therapies. These services are delivered against therapeutic protocols supplied by sponsors and are not standalone commercial products sold to consumers; rather, they constitute contracted research capacity. The site's specialized diagnostic infrastructure, particularly on-site Amyloid PET imaging, is a notable technical asset for a single-site operation focused on a therapeutic area where amyloid biomarkers are increasingly central to trial enrollment and endpoint measurement.

AMRI's revenue model is transaction-based and contract-negotiated, with income generated from per-study or milestone-based payments from pharmaceutical sponsors, biotech firms, and Contract Research Organizations (CROs). Pricing is not publicly disclosed; contracts are negotiated individually, typically on multi-year terms. The go-to-market operates on two axes: a community-led motion to recruit study participants through phone outreach, website-based study search, and social media; and an enterprise field sales motion targeting sponsors and CROs via a dedicated business development page. AMRI serves two primary segments — study participants (individuals with memory conditions and their care partners) and enterprise clients (pharmaceutical sponsors and CROs) — with the latter representing the actual revenue-generating customer base.

Name

Advanced Memory Research Institute

Legal name

Advanced Memory Research Institute

Website

https://amrinj.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Advanced Memory Research Institute is a Toms River, NJ-based clinical research site specializing in Alzheimer's, dementia, and memory loss trials. Operating within the CenExel national network, it serves pharmaceutical sponsors and CROs while recruiting study participants from the regional memory-loss community.

Ownership category

akta.pro rank

Headquarters

HQ city

Toms River

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Contracts: Revenue generated from pharmaceutical companies, biotech firms, and CROs that contract AMRI to conduct clinical trials for their drug candidates. Payment is received per completed study or milestone.
2. Study Participant Compensation: Participants receive compensation for time and travel expenses. This is an expense rather than revenue stream for the organization.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Advanced Memory Research Institute (AMRI), also operating as CenExel Toms River, is a specialized clinical research site that conducts memory loss, Alzheimer's, and dementia clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations. Within its 6,000 sq ft dedicated research facility, staffed by board-certified physicians with 50+ years of collective clinical trial experience, AMRI recruits study participants, administers investigational treatments in on-site infusion suites, performs Amyloid PET imaging diagnostics, and delivers no-cost memory evaluations.

Product overview

Advanced Memory Research Institute (AMRI), operating as CenExel Toms River, is a clinical research organization specializing in memory loss, Alzheimer's, and dementia studies. The organization offers a unified portfolio of clinical research services including clinical trials for new medications, no-cost memory evaluations, Amyloid PET imaging diagnostics, and infusion services, all delivered within a 6,000 sq ft state-of-the-art facility overseen by board-certified physicians.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Studies Clinical trials focused on memory loss, Alzheimer's, and dementia, conducted by board-certified physicians with over 50 years of collective clinical trial experience. Delivered to pharmaceutical sponsors and Contract Research Organizations under contract.
• No-Cost Memory Evaluation Free memory evaluations lasting 1-2 hours, providing participants with comprehensive cognitive assessments to determine study eligibility.
• Amyloid PET Imaging Advanced brain imaging technology used to detect amyloid plaques associated with Alzheimer's disease, used in clinical trial assessments and diagnostic evaluations.
• Infusion Services Infusion suites within the 6,000 sq ft dedicated research facility for administering intravenous investigational treatments during clinical trials.

Quantifiable outcome

• Free memory evaluations (1-2 hours) available to participants
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• CenExelcoreStrategic or Co-development PartnerCenExel is the parent organization and national clinical research network of which AMRI is a part. This affiliation provides AMRI with centralized resources, brand recognition, shared best practices, and access to a broader network of research sites and opportunities.

Scale indicators3 records

Recent moves1 record

Expansion highlights4 records

Broad incumbents

• IQVIA: The largest global CRO with broad CNS and Alzheimer's trial capabilities. A broad incumbent that competes with AMRI indirectly by offering sponsors fully integrated multi-site trial management and central lab/imaging services.
• Worldwide Clinical Trials: Mid-sized scientific-focused CRO with a strong CNS/neuroscience franchise. Comparable to AMRI in therapeutic specialization at the CRO level, though it operates at a global multi-site scale rather than as a single site.
• Medpace: Mid-sized full-service CRO with therapeutic expertise including CNS. Competes with AMRI indirectly by offering sponsors turnkey trial execution across geographies, including neurology programs.
• ICON plc: Global CRO with significant CNS and Alzheimer's experience post-PRA merger. Competes with AMRI indirectly via its large site network, central labs, and embedded biotech/sponsor relationships.

Direct peers

• Massachusetts Alzheimer's Disease Research Center (MGH): Academic ADRC at Massachusetts General Hospital running Alzheimer's and dementia clinical trials with biomarker and imaging expertise. Comparable to AMRI in therapeutic focus, though embedded in an academic medical center.
• Cleveland Clinic Lou Ruvo Center for Brain Health: Specialized brain health and Alzheimer's clinical research center within Cleveland Clinic that runs memory-loss clinical trials with dedicated imaging and infusion infrastructure, comparable to AMRI's therapeutic focus and operating model.
• Mayo Clinic Alzheimer's Disease Research Center: Mayo Clinic's ADRC conducts clinical trials in Alzheimer's and related dementias across its enterprise. Directly comparable therapeutic focus to AMRI, with broader geographic footprint and academic backing.
• UCSF Memory and Aging Center: Academic clinical research center at UCSF focused on Alzheimer's, frontotemporal dementia, and related disorders. Comparable to AMRI in therapeutic specialization, though operating with academic scale and translational research depth.
• Banner Alzheimer's Institute: A dedicated Alzheimer's disease research and treatment center conducting clinical trials and biomarker research. It is directly comparable to AMRI as another standalone site that specializes in Alzheimer's trial execution, recruitment, and PET imaging.

Emerging players

• Biotrial: Independent CRO with dedicated neuroscience and early-phase expertise, including Alzheimer's and dementia programs. Comparable to AMRI in its neuroscience focus, though it operates as a CRO rather than a single dedicated research site.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/amri_nj
• Facebookfacebook.com/advancedmemoryresearchinstitute
• LinkedInlinkedin.com/company/cenexel
• Instagraminstagram.com/explore/locations/674691559284098/advanced-memory-research-institute

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advanced Memory Research Institute